Preference And ValuE (PAVE)

In this section
Preference And ValuE (PAVE)

Theme leader: Dr Luis Loría-Rebolledo

The Preference And ValuE (PAVE) theme aims are to apply and develop economic methods of valuing health and care. Our research explores the preferences and value that individuals, patients, healthcare professionals and society places on the benefits and delivery of health and care.

We combine applied and methodological studies to inform policy and advance the methods. Our research has informed health and care policy across a range of applications, including alongside clinical trials, secondary data analysis and mixed methods.

We are internationally known for our research on Discrete Choice Experiments (DCEs) to inform health economics. Our work has allowed us to build collaborations and apply these methods across the UK and abroad.

You can read more about our current research below. For completed projects, please visit HERU's Publications page.

 
The health and well-being effects of pest rodent management strategies in rural Madagascar
HERU contact: Niamh McAuley (PhD project)
Working with: University of Aberdeen School of Biological Sciences
Suggested reading: QUADRAT Doctoral Training Partnership
 
Estimating the health and wellbeing value of the NHS outdoor estate
HERU contact: Luis Loría-Rebolledo
Working with: Scottish Environment, Food and Agriculture Research Institutions (SEFARI), Public Health Scotland, and NatureScot
Suggested reading: SEFARI blog post
 
Understanding preferences and values for a net zero NHS: England and Scotland
HERU contact: Luis Loría-Rebolledo
Working with: Dr Hangjian Wu, Newcastle University
Suggested reading: Loría-Rebolledo, L. E. et al, BMJ, 14(6), e082863.
 
PRAGMATIC - PRecision biomArker Guided MAnagement of TuberculosIs Contacts
HERU contact: Luis Loría-Rebolledo
Working with: University College London (Dr Rishi Gupta)
 
Systematic review - Discrete Choice Experiments in health studies 2018-2023
HERU contact: Luis Loría-Rebolledo
Working with: Professor Verity Watson, Dr Divya Mohan
 
PreCeDenT - Patient Priorities in Cancer and Dysplasia Treatment in Irritable Bowel Disorder
HERU contact: Luis Loría-Rebolledo
Working with: St Marks Hospital, London North West University Healthcare NHS Trust
Suggested reading: Health Research Authority application summary
 
MOPeD - Musculoskeletal Outpatient Physiotherapy Delegation: a mixed methods study
HERU contact: Luis Loría-Rebolledo
Working with: Keele University, NHS Midlands Partnership
Suggested reading: MOPeD study site
 
iDiabetes platform - enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment
HERU contact: Rodolfo Hernández
Working with: NHS Tayside and University of Dundee
Suggested reading: CSO PMAS/21/01
 
PATHWAY - PrioritisAtion of THose aWaiting hip and knee ArthroplastY
HERU contact: Mandy Ryan
Working with: Aberdeen Centre for Health Data Science
Suggested reading: PATHWAY project site
 
Beyond the diagnosis: the value of genome-wide sequencing for the diagnosis of rare conditions in Scotland
HERU contact: Michael Abbott (PhD project)
 
Public and patient preferences for social prescribing
HERU contact: Mélanie Antunes (PhD project)
Working with: Curtin University
 
Understanding public preferences and trade-offs for government responses during a pandemic
HERU contact: Luis Loría-Rebolledo
Working with: Dr Ruben Sakowsky, University Medical Center Göttingen, Germany and Dr Mesfin Genie, University of Newcastle, Australia
Suggested reading: Loría-Rebolledo, L. et al (2022) BMJ Open, 12: e054155
 
Using eye-tracking to inform the design and analysis of discrete choice experiments
HERU contact: Mandy Ryan
Working with: Dr Mesfin Genie, University of Newcastle, Australia
Suggested reading: Genie, M.G., Ryan, M. and Krucien, N. (2023) Health Economics, 32(5), 1101-1119.
 
Should Scotland provide whole genomic sequencing for diagnosis of rare disorders? A health economic analysis
HERU contact: Michael Abbott
Working with: University of Aberdeen Applied Medicine
Suggested reading: Abbott, M. et al (2024) European Journal of Health Economics